| Bioactivity | Sutezolid (PNU-100480), an orally active oxazolidinone antimicrobial agent, acts by inhibiting bacterial protein synthesis. Sutezolid has potent activity against mycobacteria, and is used for the research of drug-resistant tuberculosis[1][2]. | ||||||||||||
| Invitro | Sutezolid (PNU-100480) exhibits excellent in vitro activity against multiple clinical isolates of Mycobacterium avium complex (MIC’s=0.5-4 µg/mL)[1]. | ||||||||||||
| Name | Sutezolid | ||||||||||||
| CAS | 168828-58-8 | ||||||||||||
| Formula | C16H20FN3O3S | ||||||||||||
| Molar Mass | 353.41 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Sutezolid
CAS: 168828-58-8 F: C16H20FN3O3S W: 353.41
Sutezolid (PNU-100480), an orally active oxazolidinone antimicrobial agent, acts by inhibiting bacterial protein synthes
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.